Detalus Advisors, LLC Johnson & Johnson Transaction History

Detalus Advisors, LLC

$287 Million
Q3 2024

A detailed history of Detalus Advisors, LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Detalus Advisors, LLC holds 4,907 shares of JNJ stock, worth $705,871. This represents 0.28% of its overall portfolio holdings.

Number of Shares

4,907

Previous 4,630 5.98%

Holding current value

$705,871

Previous $676,000 17.6%

% of portfolio

0.28%

Previous 0.24%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 22, 2024	BUY	$145.48 - $167.38 $40,297 - $46,364	277 Added 5.98%	4,907 $795,000
Q2 2024 Jul 26, 2024	BUY	$144.38 - $157.78 $1,443 - $1,577	10 Added 0.22%	4,630 $676,000
Q1 2024 Apr 24, 2024	SELL	$155.22 - $162.74 $8,226 - $8,625	-53 Reduced 1.13%	4,620 $730,000
Q4 2023 Jan 24, 2024	SELL	$145.6 - $158.88 $29,411 - $32,093	-202 Reduced 4.14%	4,673 $732,000
Q3 2023 Oct 26, 2023	SELL	$155.75 - $174.48 $104,664 - $117,250	-672 Reduced 12.11%	4,875 $759,000
Q2 2023 Jul 28, 2023	BUY	$154.35 - $166.11 $77,329 - $83,221	501 Added 9.93%	5,547 $918,000
Q1 2023 May 15, 2023	SELL	$151.05 - $180.26 $11,932 - $14,240	-79 Reduced 1.54%	5,046 $782,000
Q4 2022 Feb 09, 2023	BUY	$160.2 - $179.79 $71,289 - $80,006	445 Added 9.51%	5,125 $905,000
Q3 2022 Nov 04, 2022	SELL	$161.33 - $179.52 $18,552 - $20,644	-115 Reduced 2.4%	4,680 $765,000
Q2 2022 Jul 27, 2022	SELL	$168.19 - $186.01 $57,689 - $63,801	-343 Reduced 6.68%	4,795 $851,000
Q1 2022 Apr 25, 2022	SELL	$158.14 - $179.59 $58,353 - $66,268	-369 Reduced 6.7%	5,138 $911,000
Q4 2021 Jan 18, 2022	SELL	$155.93 - $173.01 $42,257 - $46,885	-271 Reduced 4.69%	5,507 $942,000
Q3 2021 Oct 20, 2021	SELL	$161.5 - $179.47 $53,133 - $59,045	-329 Reduced 5.39%	5,778 $933,000
Q2 2021 Jul 14, 2021	BUY	$159.48 - $171.07 $63,791 - $68,428	400 Added 7.01%	6,107 $1.01 Million
Q1 2021 Apr 15, 2021	BUY	$153.07 - $170.48 $23,725 - $26,424	155 Added 2.79%	5,707 $938,000
Q4 2020 Jan 19, 2021	BUY	$137.11 - $157.38 $30,986 - $35,567	226 Added 4.24%	5,552 $874,000
Q3 2020 Nov 18, 2020	SELL	$140.38 - $153.83 $2,807 - $3,076	-20 Reduced 0.37%	5,326 $793,000
Q2 2020 Aug 13, 2020	SELL	$128.81 - $155.51 $40,832 - $49,296	-317 Reduced 5.6%	5,346 $752,000
Q1 2020 May 15, 2020	BUY	$111.14 - $153.99 $7,112 - $9,855	64 Added 1.14%	5,663 $743,000
Q4 2019 Feb 13, 2020	BUY	$127.5 - $146.44 $713,872 - $819,917	5,599 New	5,599 $817,000

Others Institutions Holding JNJ

# of Institutions

4,275

Shares Held

1.68B

Call Options Held

17.6M

Put Options Held

14.5M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $376B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Detalus Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Detalus Advisors, LLC with notifications on news.

Account

Detalus Advisors, LLC Johnson & Johnson Transaction History